Search research articles
Contact Us
Filters
Showing results (271-280 of 313) with videos related to
Page
of 32
Sort By:
Alimentary Pharmacology & Therapeutics
|
July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
Stefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
British Journal of Cancer
|
November 26, 2009
A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy
C P Lee, G S Payne, A Oregioni, et al.
Genome Research
|
January 18, 2013
Dynamic DNA methylation across diverse human cell lines and tissues
Katherine E Varley, Jason Gertz, Kevin M Bowling, et al.
Gastro Hep Advances
|
August 12, 2024
Multicenter Study of Nonadherence to Self-Injectable Biologic Therapy in Patients With Inflammatory Bowel Disease: Risk Factors and Outcomes
Lauren A George, Erin Causey, Nisha B Shah, et al.
The American Journal of Gastroenterology
|
June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch
Edward L Barnes, Laura Raffals, Taha Qazi, et al.
Digestive Diseases and Sciences
|
January 4, 2019
Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy
Zaid Bilgrami, Ameer Abutaleb, Kenechukwu Chudy-Onwugaje, et al.
Digestive Diseases and Sciences
|
December 4, 2019
Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy
Zaid Bilgrami, Ameer Abutaleb, Kenechukwu Chudy-Onwugaje, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year
Ameer Abutaleb, Andrea Buchwald, Kenechukwu Chudy-Onwugaje, et al.
The American Journal of Gastroenterology
|
July 30, 2025
Inflammatory Bowel Diseases-Specific Cognitive Behavioral Therapy Delivered Through Telehealth Reduces Disability: Addressing Disability Effectively With Psychosocial Telemedicine Pragmatic Randomized Controlled Trial
Chung Sang Tse, James D Lewis, Sara N Horst, et al.
The American Journal of Gastroenterology
|
November 10, 2018
A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)
Raymond K Cross, Patricia Langenberg, Miguel Regueiro, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 313) with videos related to
Sort By:
Page
of 32
Alimentary Pharmacology & Therapeutics
|
July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
Stefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
British Journal of Cancer
|
November 26, 2009
A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy
C P Lee, G S Payne, A Oregioni, et al.
Genome Research
|
January 18, 2013
Dynamic DNA methylation across diverse human cell lines and tissues
Katherine E Varley, Jason Gertz, Kevin M Bowling, et al.
Gastro Hep Advances
|
August 12, 2024
Multicenter Study of Nonadherence to Self-Injectable Biologic Therapy in Patients With Inflammatory Bowel Disease: Risk Factors and Outcomes
Lauren A George, Erin Causey, Nisha B Shah, et al.
The American Journal of Gastroenterology
|
June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch
Edward L Barnes, Laura Raffals, Taha Qazi, et al.
Digestive Diseases and Sciences
|
January 4, 2019
Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy
Zaid Bilgrami, Ameer Abutaleb, Kenechukwu Chudy-Onwugaje, et al.
Digestive Diseases and Sciences
|
December 4, 2019
Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy
Zaid Bilgrami, Ameer Abutaleb, Kenechukwu Chudy-Onwugaje, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year
Ameer Abutaleb, Andrea Buchwald, Kenechukwu Chudy-Onwugaje, et al.
The American Journal of Gastroenterology
|
July 30, 2025
Inflammatory Bowel Diseases-Specific Cognitive Behavioral Therapy Delivered Through Telehealth Reduces Disability: Addressing Disability Effectively With Psychosocial Telemedicine Pragmatic Randomized Controlled Trial
Chung Sang Tse, James D Lewis, Sara N Horst, et al.
The American Journal of Gastroenterology
|
November 10, 2018
A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)
Raymond K Cross, Patricia Langenberg, Miguel Regueiro, et al.
Page
of 32